Compile Data Set for Download or QSAR
maximum 50k data
Found 225 Enz. Inhib. hit(s) with all data for entry = 10029
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509297(US11072617, Example 22M12)
Affinity DataKi:  3nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509307(US11072617, Example 32M18)
Affinity DataKi:  3nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509327(US11072617, Example 52M21)
Affinity DataKi:  3nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509347(US11072617, Example 73M25)
Affinity DataKi:  3nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509414(US11072617, Example 134M29)
Affinity DataKi:  3nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509372(US11072617, Example 98M26)
Affinity DataKi:  3nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509374(US11072617, Example 100M26)
Affinity DataKi:  3nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509410(US11072617, Example 130M28)
Affinity DataKi:  3nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509370(US11072617, Example 96M26)
Affinity DataKi:  3nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509304(US11072617, Example 29M43)
Affinity DataKi:  4nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509305(US11072617, Example 30M17)
Affinity DataKi:  4nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509368(US11072617, Example 94M26)
Affinity DataKi:  4nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509396(US11072617, Example 118M28)
Affinity DataKi:  4nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509411(US11072617, Example 131M28)
Affinity DataKi:  4nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509468(US11072617, Example 183M40/sup>)
Affinity DataKi:  4nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509415(US11072617, Example 135M29)
Affinity DataKi:  4nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509417(US11072617, Example 137M29)
Affinity DataKi:  4nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509427(US11072617, Example 146M20)
Affinity DataKi:  4nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509413(US11072617, Example 133M29)
Affinity DataKi:  4nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509466(US11072617, Example 181M40/sup>)
Affinity DataKi:  4nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509437(US11072617, Example 155M32)
Affinity DataKi:  4.80nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509298(US11072617, Example 23M13)
Affinity DataKi:  5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509503(US11072617, Example 216M30)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509310(US11072617, Example 35M18)
Affinity DataKi:  5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509315(US11072617, Example 40M18)
Affinity DataKi:  5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509317(US11072617, Example 42M18)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509320(US11072617, Example 45M18)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509323(US11072617, Example 48M18)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509339(US11072617, Example 64M23)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509342(US11072617, Example 67M21)
Affinity DataKi:  5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509344(US11072617, Example 69M23)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509345(US11072617, Example 70M21)
Affinity DataKi:  5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509348(US11072617, Example 74M25)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509350(US11072617, Example 76M25)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509352(US11072617, Example 78M25)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509354(US11072617, Example 80M25)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509356(US11072617, Example 82M25)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509358(US11072617, Example 84M25)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509360(US11072617, Example 86M25)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509398(US11072617, Example 120M28)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509399(US11072617, Example 121M28 | US11072617, Example 1...)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509401(US11072617, Example 123M28)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509402(US11072617, Example 124M28)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509403(US11072617, Example 125M28)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509404(US11072617, Example 126M28)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509399(US11072617, Example 121M28 | US11072617, Example 1...)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509416(US11072617, Example 136M29)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509418(US11072617, Example 138M29)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509420(US11072617, Example 139M29)
Affinity DataKi:  5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetReceptor-interacting serine/threonine-protein kinase 1 [2-375](Homo sapiens (Human))
Genentech

US Patent
LigandPNGBDBM509422(US11072617, Example 141M30)
Affinity DataKi: <5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 225 total ) | Next | Last >>
Jump to: